American Century Companies Inc. Grows Holdings in Nutex Health Inc. $NUTX

American Century Companies Inc. increased its holdings in Nutex Health Inc. (NASDAQ:NUTX) by 73.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,359 shares of the company’s stock after acquiring an additional 31,366 shares during the quarter. American Century Companies Inc. owned about 1.35% of Nutex Health worth $3,497,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. Ancora Advisors LLC bought a new stake in Nutex Health during the fourth quarter worth about $1,334,000. Informed Momentum Co LLC purchased a new position in shares of Nutex Health during the first quarter valued at approximately $868,000. Scissortail Wealth Management LLC lifted its holdings in shares of Nutex Health by 485,900.0% during the fourth quarter. Scissortail Wealth Management LLC now owns 9,720 shares of the company’s stock valued at $308,000 after purchasing an additional 9,718 shares during the last quarter. Squarepoint Ops LLC bought a new stake in shares of Nutex Health in the 4th quarter worth approximately $285,000. Finally, OMERS ADMINISTRATION Corp purchased a new stake in shares of Nutex Health in the 4th quarter worth approximately $231,000. 5.32% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Maxim Group set a $205.00 price objective on Nutex Health and gave the company a “buy” rating in a research report on Tuesday. Benchmark increased their target price on Nutex Health from $150.00 to $300.00 and gave the stock a “buy” rating in a research note on Thursday, May 15th. Finally, Wall Street Zen downgraded Nutex Health from a “strong-buy” rating to a “buy” rating in a report on Thursday, May 22nd. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Nutex Health has an average rating of “Buy” and a consensus target price of $252.50.

Nutex Health Price Performance

Shares of NASDAQ NUTX opened at $83.79 on Friday. The firm has a market cap of $465.87 million, a P/E ratio of 7.05 and a beta of 0.05. Nutex Health Inc. has a twelve month low of $17.51 and a twelve month high of $184.27. The company has a quick ratio of 2.26, a current ratio of 2.27 and a debt-to-equity ratio of 1.02. The company has a 50 day moving average of $103.30 and a 200 day moving average of $103.28.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.